More on endometrial cancer and tamoxifen
Arnold, A.
Journal of the National Cancer Institute 86(24): 1877-1878
1994
ISSN/ISBN: 0027-8874 PMID: 7990165 Document Number: 427936
Document emailed within 1 workday
Related Documents
Neri, F.; Maggino, T. 2009: Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment European Journal of Gynaecological Oncology 30(4): 357-360Sinawat, S.; Chiyabutra, T.; Kleabkaew, P. 2001: Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report Journal of the Medical Association of Thailand 84(7): 1033-1036
Kochar, S.; Arora, P.; Chattopadhyay, A.B. 2005: Tamoxifen Therapy for Breast Cancer and Endometrial Pathology Medical Journal Armed Forces India 61(4): 313-315
Krause, A.; Gerber, B. 1994: Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy Zentralblatt für Gynakologie 116(1): 44-47
Dominick, S.; Hickey, M.; Chin, J.; Su, H.I. 2015: Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen Cochrane Database of Systematic Reviews 12: Cd007245
Ivanova, V.; Karaivanov, M.; Raĭcheva, S.; Marinov, E.; Gorchev, G. 2004: Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex) Akusherstvo i Ginekologiia 43(2): 33-36
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204
Sinawat, S.; Chiyabutra, T. 2004: Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study Journal of the Medical Association of Thailand 87 Suppl. 3: S59-S63
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Kahraman, K.; Pabuccu, E.; Taskin, S.; Sukur, Y.E.; Ozmen, B.; Ortac, F. 2011: The role of ultrasound and symptom-based triage for detection of pathological endometrial changes in patients undergoing tamoxifen therapy for breast cancer European Journal of Gynaecological Oncology 32(6): 667-671
Lindahl, B.; Andolf, E.; Ingvar, C.; Ranstam, J.; Willén, R. 2008: Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma Anticancer Research 28(2b): 1259-1262
Aleem, F.A.; Predanic, M. 1995: Endometrial changes in patients on tamoxifen Lancet 346(8985): 1292-1293
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Erdemoglu, E.; Güney, M.; Keskin, B.; Mungan, T. 2008: Tamoxifen and giant endometrial polyp European Journal of Gynaecological Oncology 29(2): 198-199
Neven, P. 1991: Endometrial changes in patients receiving tamoxifen therapy New York State Journal of Medicine 91(4): 168
De Muylder, X. 1999: Benign endometrial lesions induced by tamoxifen Journal de Gynecologie Obstetrique et Biologie de la Reproduction 28(5): 420-424
Perlman, S.; Vaisbuch, E.; Ben-Arie, A. 2006: Tamoxifen treatment and malignant endometrial tumors--what's new? Harefuah 145(3): 219-22 244
Gelmann, E.P. 1997: Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma Seminars in Oncology 24(1 Suppl 1: S1
Steiner, A. 1999: Transvaginal endometrial sonography in postmenopausal women taking tamoxifen Obstetrics and Gynecology 94(2): 321-322
Felix, A.S.; Gaudet, M.M.; La Vecchia, C.; Nagle, C.M.; Shu, X.O.; Weiderpass, E.; Adami, H.O.; Beresford, S.; Bernstein, L.; Chen, C.; Cook, L.S.; De Vivo, I.; Doherty, J.A.; Friedenreich, C.M.; Gapstur, S.M.; Hill, D.; Horn-Ross, P.L.; Lacey, J.V.; Levi, F.; Liang, X.; Lu, L.; Magliocco, A.; McCann, S.E.; Negri, E.; Olson, S.H.; Palmer, J.R.; Patel, A.V.; Petruzella, S.; Prescott, J.; Risch, H.A.; Rosenberg, L.; Sherman, M.E.; Spurdle, A.B.; Webb, P.M.; Wise, L.A.; Xiang, Y.-B.; Xu, W.; Yang, H.P.; Yu, H.; Zeleniuch-Jacquotte, A.; Brinton, L.A. 2015: Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium International Journal of Cancer 136(5): E410-E422